PBPK Models to Aid the Development of Generic Dermatological Products

PBPK modeling and simulation tools have been extremely useful tool in the drug development process, in the interaction with regulatory agencies, and in decision making in the clinical setting.

The objective of this NOFO is to promote further enhancements to improve the predictive power of these

modeling and simulation tools and to expand their capabilities in leveraging observed data collected in vivo and in vitro data towards model development and validation.

Goals of this research could include:1) Incorporation of formulation attributes such as a.

viscosity impacting drug release and stratum corneum permeation, b.

Q1/Q2 information leveraged to predict evaporation profiles based on Q2 component) to improve the predictive power of the existing modeling tools.2) Incorporation of new or modification of existing formulation attributes that would allow predicting skin permeation for drug products with unique drug release technologies such as microneedles or iontophoresis3) Development of an in silico in vitro permeation testing module that may support formulation development strategies, formulation selection, inform in vivo PBPK model development by leveraging experimental IVPT data and conduct BE assessments between R and T drug products.

Further leverage this module to design IVPT studies that may be clinically relevant and discriminatory at the same time.4) Incorporation of novel approaches in accounting for excipient effects on skin permeation which may include parallel permeation for both API and excipient or identifying excipient-impacted permeation parameters for the API.5) Enhancements of skin physiology models to include skin metabolism with metabolite tracking (develop novel methodologies), enhancements on stratum corneum morphology such as protein binding, and corneocyte dimensions intended to improve prediction for lipophilic compounds).6) Generation of new experimental data as appropriate to support the other goals
Related Programs

Food and Drug Administration_Research

Department of Health and Human Services


Agency: Department of Health and Human Services

Office: Food and Drug Administration

Estimated Funding: $4,000,000


Relevant Nonprofit Program Categories





Obtain Full Opportunity Text:
USFS Landscape Scale Restoration grants web page

Additional Information of Eligibility:
This MURI competition is open only to and full proposals are to be submitted only by, U. S. institutions of higher education (universities) including DoD institutions of higher education, with degree-granting programs in science and/or engineering.

To the extent that it is a part of a U. S. institution of higher education and is not designated as an FFRDC, a University Affiliated Research Center (UARC) or other University Affiliated Laboratory (UAL) is eligible to submit a proposal to this MURI competition and receive MURI funds.

Full Opportunity Web Address:
https://www.fs.usda.gov/naspf/working-with-us/grants/landscape-scale-restoration-grants

Contact:


Agency Email Description:
shashi.malhotra@fda.hhs.gov

Agency Email:


Date Posted:
2021-05-25

Application Due Date:


Archive Date:
2021-05-26



A¬†recruiting trends report¬†by Michigan State University‚Äôs (MSU) Collegiate Employment Research Institute discovers that¬†the financial services sector is decreasing the¬†hiring rate for Bachelor‚Äôs degrees from ‚Äúdouble-digit expansion‚ÄĚ.




Not for Profit Jobs in Missouri

  Program Director Jobs
  Executive Director Jobs
  Social Services Jobs
  Substance Abuse Jobs
  Fundraising & Development Jobs





More Federal Domestic Assistance Programs


ASPR Science Preparedness and Reponse Grants | Childhood Lead Poisoning Prevention Projects_State and Local Childhood Lead Poisoning Prevention and | Choice Neighborhoods | Safety Incentives to Prevent Operation of Motor Vehicles by Intoxicated Persons | Social Security Work Incentives Planning and Assistance Program |  Site Style by YAML | Grants.gov | Grants | Grants News | Sitemap | Privacy Policy


Edited by: Michael Saunders

© 2004-2021 Copyright Michael Saunders